Insider · CIK 0002085820
Megan Lesko Pacchia
Files at SVIA (ProCap Financial, Inc.). First filing -, latest -.
Megan Lesko Pacchia files SEC Form 4 as COO at SVIA (ProCap Financial, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Megan Lesko Pacchia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | SVIA ProCap Financial, Inc. | FTax withholding Common Stock | -30,415 | $3.22 | $98k | 248,535 | 28 d ago |
| Mar 23, 2026 | SVIA ProCap Financial, Inc. | AGrant or award Common Stock, par value $0.001 | +110,000 | $0.00 | $0 | 110,000 | Mar 25, 2026 |
| Mar 23, 2026 | SVIA ProCap Financial, Inc. | FTax withholding Common Stock, par value $0.001 | -47,408 | $2.62 | $124k | 62,592 | Mar 25, 2026 |
Questions about Megan Lesko Pacchia
Answered from the filings on this page, as of the latest one.
Is Megan Lesko Pacchia buying or selling?
Megan Lesko Pacchia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Megan Lesko Pacchia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Megan Lesko Pacchia has 0.
Where does Megan Lesko Pacchia file Form 4?
Megan Lesko Pacchia has filed Form 4 at SVIA (ProCap Financial, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.